These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38051204)

  • 1. Pharmacists Colocated With Primary Care Physicians: Understanding Delivery of Interprofessional Primary Care.
    Hawes EM; Page C; Galloway E; McClurg MR; Lombardi B
    Med Care; 2024 Feb; 62(2):87-92. PubMed ID: 38051204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping colocation: Using national provider identified data to assess primary care and behavioral health colocation.
    Richman EL; Lombardi BM; Zerden LD
    Fam Syst Health; 2020 Mar; 38(1):16-23. PubMed ID: 32202831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary care, behavioral health, provider colocation, and rurality.
    Miller BF; Petterson S; Brown Levey SM; Payne-Murphy JC; Moore M; Bazemore A
    J Am Board Fam Med; 2014; 27(3):367-74. PubMed ID: 24808115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are DEA-waivered buprenorphine prescribers colocated with behavioral health clinicians?
    Zerden LS; Sullivan C; Galloway E; Richman EL; Gaiser MG; Lombardi B
    Am J Addict; 2023 Nov; 32(6):574-583. PubMed ID: 37559344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmaceutical Role Expansion and Developments in Pharmacist-Physician Communication.
    Bergman AA; Jaynes HA; Gonzalvo JD; Hudmon KS; Frankel RM; Kobylinski AL; Zillich AJ
    Health Commun; 2016; 31(2):161-70. PubMed ID: 26266465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of assessing where colocation is occurring. Commentary on Richman, Lombardi, and Zerden (2020).
    Nielsen M
    Fam Syst Health; 2020 Mar; 38(1):24-25. PubMed ID: 32202832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacist and physician satisfaction and rates of switching to preferred medications associated with an instant prior authorization program for proton pump inhibitors in the North Carolina Medicaid program.
    Jacobson Vann JC; Christofferson S; Humble CG; Wegner SE; Feaganes JR; Trygstad TK
    J Manag Care Pharm; 2010 May; 16(4):250-63. PubMed ID: 20433216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medicaid Costs and Utilization of Collaborative Versus Colocation Care for Patients With Depression.
    Chung H; Patel U; Stein D; Collado K; Blackmore M
    Psychiatr Serv; 2023 Nov; 74(11):1132-1136. PubMed ID: 37221885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating Pharmacist-Written Recommendations to Providers in a Medicare Advantage Plan: Factors Associated with Provider Acceptance.
    Mann A; Esse T; Abughosh SM; Serna O
    J Manag Care Spec Pharm; 2016 Jan; 22(1):49-55. PubMed ID: 27015051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective trial of a clinical pharmacy intervention in a primary care practice in a capitated payment system.
    Altavela JL; Jones MK; Ritter M
    J Manag Care Pharm; 2008; 14(9):831-43. PubMed ID: 19006440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physician and Pharmacist Medication Decision-Making in the Time of Electronic Health Records: Mixed-Methods Study.
    Mercer K; Burns C; Guirguis L; Chin J; Dogba MJ; Dolovich L; Guénette L; Jenkins L; Légaré F; McKinnon A; McMurray J; Waked K; Grindrod KA
    JMIR Hum Factors; 2018 Sep; 5(3):e24. PubMed ID: 30274959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Pharmacists on Access to Vaccine Providers: A Geospatial Analysis.
    Shah PD; Trogdon JG; Golden SD; Golin CE; Marciniak MW; Brewer NT
    Milbank Q; 2018 Sep; 96(3):568-592. PubMed ID: 30203603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Availability of primary care providers and pharmacists in the United States.
    Knapp KK; Paavola FG; Maine LL; Sorofman B; Politzer RM
    J Am Pharm Assoc (Wash); 1999; 39(2):127-35. PubMed ID: 10079647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physician experiences with clinical pharmacists in primary care teams.
    Moreno G; Lonowski S; Fu J; Chon JS; Whitmire N; Vasquez C; Skootsky SA; Bell DS; Maranon R; Mangione CM
    J Am Pharm Assoc (2003); 2017; 57(6):686-691. PubMed ID: 28811089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Frequency of Encounters With Primary Care Physicians vs Visits to Community Pharmacies Among Medicare Beneficiaries.
    Berenbrok LA; Gabriel N; Coley KC; Hernandez I
    JAMA Netw Open; 2020 Jul; 3(7):e209132. PubMed ID: 32667653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Healthcare provider perceptions of the role of interprofessional care in access to and outcomes of primary care in an underserved area.
    Wan S; Teichman PG; Latif D; Boyd J; Gupta R
    J Interprof Care; 2018 Mar; 32(2):220-223. PubMed ID: 29083272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Pharmacists' Work in a Physician-Pharmacist Collaborative Model for the Management of Hypertension.
    Isetts BJ; Buffington DE; Carter BL; Smith M; Polgreen LA; James PA
    Pharmacotherapy; 2016 Apr; 36(4):374-84. PubMed ID: 26893135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Communication between pharmacists and primary care physicians in the midst of a U.S. opioid crisis.
    Curran GM; Freeman PR; Martin BC; Teeter BS; Drummond KL; Bradley K; Thannisch MM; Mosley CL; Schoenberg N; Edlund M
    Res Social Adm Pharm; 2019 Aug; 15(8):974-985. PubMed ID: 30170901
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.